CX3CR1 and breast carcinoma: Breast cancer cells intracardially injected in total CX3CR1 KO mice had reduced bone metastases compared to wildtype mice, and bone metastases in wildtype mice were reduced with CX3CR1 antagonist treatment (224, 225).